Compare HOG & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOG | GRDN |
|---|---|---|
| Founded | 1903 | 2004 |
| Country | United States | United States |
| Employees | 6400 | 3600 |
| Industry | Motor Vehicles | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 1994 | N/A |
| Metric | HOG | GRDN |
|---|---|---|
| Price | $24.25 | $38.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $24.00 | ★ $40.60 |
| AVG Volume (30 Days) | ★ 2.7M | 355.8K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $4,473,175,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.79 | $7.63 |
| P/E Ratio | ★ $109.59 | $117.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.09 | $19.17 |
| 52 Week High | $31.25 | $41.36 |
| Indicator | HOG | GRDN |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 58.82 |
| Support Level | $22.36 | $31.74 |
| Resistance Level | $24.83 | $39.62 |
| Average True Range (ATR) | 0.96 | 1.43 |
| MACD | -0.19 | 0.26 |
| Stochastic Oscillator | 40.09 | 78.30 |
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.